MicroRNA-451b Participates in Coronary Heart Disease By Targeting VEGFA

Overview

Journal Open Med (Wars)

Specialty General Medicine

Date 2020 Jan 11

PMID 31922013

Citations 12

Authors

Jie Lin

Jun Jiang

Ruifang Zhou

Xiaojie Li

Jun Ye

Affiliations

Soon will be listed here.

Abstract

Coronary artery disease (CAD) is one of the main causes of hospitalization worldwide and has high morbidity. MicroRNAs (miRNAs) play an important role in the pathogenesis of cardiovascular diseases. miR-451 is a special miRNA that is involved in many cancers' development. At present, there is no research about miR-451 in coronary heart disease. In this study, we aimed to identify the action mechanism of miR-451 in coronary heart disease and human umbilical vein endothelial cells (HUVECs). In this study, we found that miR-451 is up-regulated in the peripheral blood of patients with coronary heart disease. Moreover, TargetScan and dual-luciferase reporter gene assay results showed that VEGFA is a direct target gene of miR-451. C (CCK-8) and flow cytometry assay results showed that miR-451 mimic significantly inhibits cell proliferation and promotes apoptosis in HUVECs. Moreover, we found that the role of miR-451 in HUVECs is associated with the PI3K-Akt-mTOR pathway. Taken together, the data indicates that miR-451 might be a novel bio-marker for coronary heart disease.

Citing Articles

MiR-451 in Inflammatory Diseases: Molecular Mechanisms, Biomarkers, and Therapeutic Applications-A Comprehensive Review Beyond Oncology.

Wang F, Mu G, Yu Z, Qin Z, Zhao X, Shi Z Curr Issues Mol Biol. 2025; 47(2).

PMID: 39996848 PMC: 11854642. DOI: 10.3390/cimb47020127.

New Biomarkers for Cardiovascular Disease.

Kim S, Mesquita F, Hochman-Mendez C Tex Heart Inst J. 2023; 50(5).

PMID: 37846107 PMC: 10658139. DOI: 10.14503/THIJ-23-8178.

Identification of 5 hub genes for diagnosis of coronary artery disease.

Zhu P, Huang H, Xie T, Liang H, Li X, Li X Front Cardiovasc Med. 2023; 10:1086127.

PMID: 37476576 PMC: 10354867. DOI: 10.3389/fcvm.2023.1086127.

Comprehensive Landscape of Modules-Dysregulated Functions Reveals a Profound Role of ceRNAs in Coronary Heart Disease.

Chen C, Feng Q, Liu Q, Wang L, Huang S J Healthc Eng. 2023; 2022:4547413.

PMID: 37342178 PMC: 10279495. DOI: 10.1155/2022/4547413.

MicroRNAs as Biomarkers for Coronary Artery Disease Related to Type 2 Diabetes Mellitus-From Pathogenesis to Potential Clinical Application.

Szydelko J, Matyjaszek-Matuszek B Int J Mol Sci. 2023; 24(1).

PMID: 36614057 PMC: 9820734. DOI: 10.3390/ijms24010616.

References

Ranganathan K, Sivasankar V . MicroRNAs - Biology and clinical applications. J Oral Maxillofac Pathol. 2014; 18(2):229-34. PMC: 4196292. DOI: 10.4103/0973-029X.140762. View

Wang R, Wang Z, Yang J, Pan X, De W, Chen L . MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14). Oncogene. 2011; 30(23):2644-58. DOI: 10.1038/onc.2010.642. View

Ameres S, Zamore P . Diversifying microRNA sequence and function. Nat Rev Mol Cell Biol. 2013; 14(8):475-88. DOI: 10.1038/nrm3611. View

Liu X, Zhang A, Xiang J, Lv Y, Zhang X . miR-451 acts as a suppressor of angiogenesis in hepatocellular carcinoma by targeting the IL-6R-STAT3 pathway. Oncol Rep. 2016; 36(3):1385-92. DOI: 10.3892/or.2016.4971. View

Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V . Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2095-128. PMC: 10790329. DOI: 10.1016/S0140-6736(12)61728-0. View

Khan A, Betel D, Miller M, Sander C, Leslie C, Marks D . Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs. Nat Biotechnol. 2009; 27(6):549-55. PMC: 2782465. DOI: 10.1038/nbt.1543. View

Nan Y, Guo H, Guo L, Wang L, Ren B, Yu K . MiRNA-451 Inhibits Glioma Cell Proliferation and Invasion Through the mTOR/HIF-1α/VEGF Signaling Pathway by Targeting CAB39. Hum Gene Ther Clin Dev. 2018; 29(3):156-166. DOI: 10.1089/humc.2018.133. View

Tully P, Baumeister H . Collaborative care for the treatment of comorbid depression and coronary heart disease: a systematic review and meta-analysis protocol. Syst Rev. 2014; 3:127. PMC: 4214823. DOI: 10.1186/2046-4053-3-127. View

Ambros V . The functions of animal microRNAs. Nature. 2004; 431(7006):350-5. DOI: 10.1038/nature02871. View

10.

Sondermeijer B, Bakker A, Halliani A, de Ronde M, Marquart A, Tijsen A . Platelets in patients with premature coronary artery disease exhibit upregulation of miRNA340* and miRNA624*. PLoS One. 2011; 6(10):e25946. PMC: 3192762. DOI: 10.1371/journal.pone.0025946. View

11.

Kovalchuk O, Filkowski J, Meservy J, Ilnytskyy Y, Tryndyak V, Chekhun V . Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin. Mol Cancer Ther. 2008; 7(7):2152-9. DOI: 10.1158/1535-7163.MCT-08-0021. View

12.

Bitarte N, Bandres E, Boni V, Zarate R, Rodriguez J, Gonzalez-Huarriz M . MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells. Stem Cells. 2011; 29(11):1661-71. DOI: 10.1002/stem.741. View

13.

Souza P, Marcadenti A, Portal V . Effects of Olive Oil Phenolic Compounds on Inflammation in the Prevention and Treatment of Coronary Artery Disease. Nutrients. 2017; 9(10). PMC: 5691704. DOI: 10.3390/nu9101087. View

14.

Nan Y, Han L, Zhang A, Wang G, Jia Z, Yang Y . MiRNA-451 plays a role as tumor suppressor in human glioma cells. Brain Res. 2010; 1359:14-21. DOI: 10.1016/j.brainres.2010.08.074. View

15.

Khera A, Kathiresan S . Genetics of coronary artery disease: discovery, biology and clinical translation. Nat Rev Genet. 2017; 18(6):331-344. PMC: 5935119. DOI: 10.1038/nrg.2016.160. View

16.

Srivastava R . Dysfunctional HDL in diabetes mellitus and its role in the pathogenesis of cardiovascular disease. Mol Cell Biochem. 2017; 440(1-2):167-187. DOI: 10.1007/s11010-017-3165-z. View

17.

Wang Y, Zhang F, Wang J, Hu L, Jiang F, Chen J . lncRNA LOC100132354 promotes angiogenesis through VEGFA/VEGFR2 signaling pathway in lung adenocarcinoma. Cancer Manag Res. 2018; 10:4257-4266. PMC: 6178939. DOI: 10.2147/CMAR.S177327. View

18.

Ren J, Zhang J, Xu N, Han G, Geng Q, Song J . Signature of circulating microRNAs as potential biomarkers in vulnerable coronary artery disease. PLoS One. 2013; 8(12):e80738. PMC: 3855151. DOI: 10.1371/journal.pone.0080738. View

19.

Kondkar A, Abu-Amero K . Utility of circulating microRNAs as clinical biomarkers for cardiovascular diseases. Biomed Res Int. 2015; 2015:821823. PMC: 4330947. DOI: 10.1155/2015/821823. View

20.

Mizuno Y, Jacob R, Mason R . Inflammation and the development of atherosclerosis. J Atheroscler Thromb. 2011; 18(5):351-8. DOI: 10.5551/jat.7591. View